| Cindy Memmott Woodings, | |
|
7500 N Calle Sin Envidia, Tucson, AZ 85718-7300 | |
| (520) 742-6242 | |
| Not Available |
| Full Name | Cindy Memmott Woodings |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 7500 N Calle Sin Envidia, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568170736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5034 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cindy Memmott Woodings, 11924 N Centaurus Pl, Tucson, AZ 85737-3455 Ph: (520) 661-6966 | Cindy Memmott Woodings, 7500 N Calle Sin Envidia, Tucson, AZ 85718-7300 Ph: (520) 742-6242 |
News Archive
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.
Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer.
From uncovering the role nerve cells play in metastasis to identifying new cancer-causing genes, researchers at Albert Einstein College of Medicine of Yeshiva University made notable advances in the understanding and potential treatment of cancer during the past year.
The Group B Streptococcus is still the most common cause of bacterial meningitis in newborns, concludes a seven-year French study in the March issue of The Pediatric Infectious Disease Journal.
Verax Biomedical today announced that the company has gained FDA clearance to expand the use of its Verax Platelet PGD test—a rapid test for the detection of bacterial contamination in platelets intended for transfusion. The new FDA clearance makes the Verax Platelet PGD test the only rapid test on the market cleared by the FDA to check every commonly distributed platelet type in the United States.
› Verified 7 days ago
Teresa Ramona Karjalainen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 720-404-0816 | |
Ashley Rae Holten, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2002 S Kelvin Stra, Tucson, AZ 85713 Phone: 719-304-1256 | |
Michael Cauble, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 6231 N Montebella Rd, Tucson, AZ 85704 Phone: 520-500-8348 | |
Mrs. Susan L. Johnson Lucht, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Danielle Marie Stradling, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 916-220-0518 | |
Graciela Contreras, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 520-225-6000 | |
Gail Abbey, O.T. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2500 N Rosemont Blvd, Tucson, AZ 85712 Phone: 520-325-4800 |